Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I1WN
|
||||
Former ID |
DNC009976
|
||||
Drug Name |
1,10-(methylenedi-4,1-phenylene)bismaleimide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530251] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H14N2O4
|
||||
Canonical SMILES |
C1=CC(=CC=C1CC2=CC=C(C=C2)N3C(=O)C=CC3=O)N4C(=O)C=CC4=O
|
||||
InChI |
1S/C21H14N2O4/c24-18-9-10-19(25)22(18)16-5-1-14(2-6-16)13-15-3-7-17(8-4-15)23-20(26)11-12-21(23)27/h1-12H,13H2
|
||||
InChIKey |
XQUPVDVFXZDTLT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530251] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.